FCMT
ELOS

Founders Capital Management (Texas)’s Syneron Medical Ltd ELOS Stock Holding History

Founders Capital Management (Texas)’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,200
Closed -$14K – 369
2017
Q2 		$14K Buy
1,200
+600
+100% +$6.58K 0.01% 249
2017
Q1 		$6K Buy
+600
New +$5.8K 0.01% 339

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Founders Capital Management (Texas)'s ELOS Position: Q3 2017 in Review

Founders Capital Management (Texas) sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 1,200 shares — an estimated $14K sold.

Founders Capital Management (Texas) first reported a position in ELOS in Q1 2017 and held it in 2 quarters. The position peaked at $14K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Founders Capital Management (Texas) reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 1,200 Syneron Medical Ltd shares in Q3 2017, an estimated $14K.
  • Founders Capital Management (Texas) first reported a position in Syneron Medical Ltd in Q1 2017 and held it in 2 quarters.
  • Founders Capital Management (Texas)'s Syneron Medical Ltd position peaked at $14K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Founders Capital Management (Texas)'s 13F filing for Q3 2017, filed 17 Oct 2017.